Latest News


October 6, 2021

A selective antibiotic for Lyme disease

Nadja Leimer, Xiaoqian Wu, Yu Imai, Linden T. Hu, Helen I. Zgurskaya, Kim Lewis

October 1, 2020

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

November 16, 2009

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi

By Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ


Pat Smith Presents Milestones in 47 Year History of Lyme Disease & Her Story


LDA Announces HHS Request for Info: Vector-Borne Diseases National Strategy


LDA & Duke/PTLD/Doxy/Lyme Med/Lyme Carditis/COVID Brains/Long COVID/Ticks, AL Deer/COVID-Lyme Clinic/Long-Haul App/HHS COVID Rep./Lyme Pregnancy/New 2 Tier/Babesia/Repellents/VA TBD/Film/LymeX/Gifts


Donate to #GiveLDA Today to Continue 32 Years of Patient Support!


HHS Publishes Third Report in Series Aimed to Improve Support for Long COVID Patients


LivLyme Foundation Launches New App That Tracks Long-Haul Disease Symptoms